Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer [6]

New England Journal of Medicine

Volumn 363, Issue 24, 2010, Pages 2371-

  Naito, Yoichi ^a   Miura, Yuji ^a   Takano, Toshimi ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; LETTER; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; ABDOMINAL RADIOGRAPHY; ADJUVANT THERAPY; MORTALITY; NOTE; OVARY TUMOR; SURVIVAL;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; NEOADJUVANT THERAPY; OVARIAN NEOPLASMS; PROGNOSIS; RADIOGRAPHY, ABDOMINAL; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649902341     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Ibeanu OA, Bristow RE. Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review. Int J Gynecol Cancer 2010;20:Suppl 1:S1-S11.
2. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-72.